A comparison of inhalational induction of anaesthesia between incremental doses of sevoflurane and high dose sevoflurane in children under 2 years of age
| ISRCTN | ISRCTN05541118 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN05541118 |
| Protocol serial number | N0265006729 |
| Sponsor | Department of Health |
| Funder | University Hospital Birmingham NHS Trust (UK) |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 13/03/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr P Townsend
Scientific
Scientific
Anaesthetics
Queen Elizabeth Hospital
Birmingham
B15 2TH
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | We intend to carry out a prospective, randomised trial comparing the use of incremental or high dose sevoflurane with O2/N2O for the induction of children under two years of age, to investigate this observed reaction to sevoflurane. We expect to see bradycardias only in the high dose group. Both methods are standard induction techniques. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Anaesthesia in elective surgery |
| Intervention | With parental consent, all children scheduled to undergo elective surgery who are to receive an inhalational induction will be eligible. Patients will be randomised to receive either incremental or high dose sevoflurane. The rate will be electronically recorded during induction of anaesthesia. Data will be subsequently analysed for alterations of heart rate: severe bradycardia being defined as a 20% reduction in heart rate from the baseline. |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Sevoflurane |
| Primary outcome measure(s) |
Data will be subsequently analysed for alterations of heart rate: severe bradycardia being defined as a 20% reduction in heart rate from the baseline. |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/01/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Upper age limit | 2 Years |
| Sex | All |
| Key inclusion criteria | Children under two years of age with parental consent, all children scheduled to undergo elective surgery who are to receive an inhalational induction will be eligible. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/2000 |
| Date of final enrolment | 01/01/2007 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Anaesthetics
Birmingham
B15 2TH
United Kingdom
B15 2TH
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |